Search

everythinglearnresearchcommunity

for

Search:↓

Heparan sulfate is important for hair growth, preventing new hair formation in mature skin, and controlling oil gland development.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Male skin gets drier and more alkaline as it ages, which may need different skincare than women's skin.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.

To treat tinea capitis in children, oral antifungal medication is necessary, with newer drugs offering shorter treatment times than the traditional griseofulvin.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Good preoperative assessment is crucial for safe and effective eyelid and brow cosmetic surgery.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Oral zinc sulphate reduces dark hair color in mice.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Thymosin β4 helps improve skin healing and reduce scarring.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The normal human prostate does not significantly affect blood DHT levels.

Ancient Chinese goats evolved cashmere-producing traits due to selective breeding, particularly in genes affecting hair growth.

Immune cells affect hair growth and could lead to new hair loss treatments.

Activating TRPV3 reduces skin oil production and increases inflammation, potentially causing dry skin issues.

A special microbe helps plants absorb rock phosphate by growing on their root hairs.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.